• Kafka MP (1991). Successful antidepressant treatment of nonparaphilic sexual addictions and paraphilias in men.
Clin Psychiatry 1991 Feb;52(2):60-5. • Kafka MP, Prentky RA (1992). Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men.
J Clin Psychiatry 1992 Oct;53(10):351-8. • Kafka MP, Prentky RA (1992). A comparative study of nonparaphilic sexual addictions and paraphilias in men.
J Clin Psychiatry 1992 Oct;53(10):345-50. • Kafka MP, Prentky RA (1994). Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: an open trial.
Ann Clin Psychiatry 1994 Sep;6(3):189-95. • Kafka MP, Prentky RA (1994). Preliminary observations of DSM-III-R axis I comorbidity in men with paraphilias and paraphilia-related disorders.
J Clin Psychiatry 1994 Nov;55(11):481-7. • Kafka MP (1997). A Monoamine Hypothesis for the Pathophysiology of Paraphilic Disorders.
Archives of Sexual Behavior Volume 26, Number 4, August 1997, pp. 343–358(16). • Kafka MP (1997). Hypersexual desire in males: an operational definition and clinical implications for males with paraphilias and paraphilia-related disorders.
Archives of Sexual Behavior 1997 Oct;26(5):505-26. • Kafka MP, Prentky RA (1998). Attention-deficit/hyperactivity disorder in males with paraphilias and paraphilia-related disorders: a comorbidity study.
J Clin Psychiatry. 1998 Jul;59(7):388-96; quiz 397. • Kafka MP, Hennen J (2002). A DSM-IV Axis I comorbidity study of males (n= 120) with paraphilias and paraphilia-related disorders.
Sexual Abuse: A Journal of Research and Treatment. Volume 14, Number 4, October 2002, pp. 349–366(18). ==Notes==